[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2013 [#4]

Announcement Date
24-Feb-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Dec-2013 [#4]
Profit Trend
QoQ- 20.39%
YoY- -10.55%
Quarter Report
View:
Show?
Annualized Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 1,994,440 1,987,488 1,874,688 1,946,639 1,838,372 1,875,944 2,001,356 -0.23%
PBT 116,968 125,562 152,636 92,997 79,986 93,058 147,696 -14.38%
Tax -40,162 -40,356 -46,052 -36,236 -32,661 -30,410 -47,084 -10.04%
NP 76,805 85,206 106,584 56,761 47,325 62,648 100,612 -16.45%
-
NP to SH 76,196 84,384 104,868 55,200 45,849 61,272 99,084 -16.04%
-
Tax Rate 34.34% 32.14% 30.17% 38.96% 40.83% 32.68% 31.88% -
Total Cost 1,917,634 1,902,282 1,768,104 1,889,878 1,791,046 1,813,296 1,900,744 0.59%
-
Net Worth 507,513 502,162 515,022 486,754 473,857 481,681 484,829 3.09%
Dividend
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Div 55,239 41,415 41,408 41,477 33,903 35,323 35,303 34.74%
Div Payout % 72.50% 49.08% 39.49% 75.14% 73.95% 57.65% 35.63% -
Equity
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Net Worth 507,513 502,162 515,022 486,754 473,857 481,681 484,829 3.09%
NOSH 258,935 258,846 258,805 258,911 258,938 258,968 117,676 69.09%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin 3.85% 4.29% 5.69% 2.92% 2.57% 3.34% 5.03% -
ROE 15.01% 16.80% 20.36% 11.34% 9.68% 12.72% 20.44% -
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
RPS 770.25 767.82 724.36 751.85 709.97 724.39 1,700.72 -40.99%
EPS 29.43 32.60 40.52 21.32 17.71 23.66 84.20 -50.34%
DPS 21.33 16.00 16.00 16.02 13.09 13.64 30.00 -20.32%
NAPS 1.96 1.94 1.99 1.88 1.83 1.86 4.12 -39.03%
Adjusted Per Share Value based on latest NOSH - 258,868
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
RPS 138.38 137.90 130.07 135.07 127.55 130.16 138.86 -0.23%
EPS 5.29 5.85 7.28 3.83 3.18 4.25 6.87 -15.97%
DPS 3.83 2.87 2.87 2.88 2.35 2.45 2.45 34.65%
NAPS 0.3521 0.3484 0.3573 0.3377 0.3288 0.3342 0.3364 3.08%
Price Multiplier on Financial Quarter End Date
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Date 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 -
Price 4.63 4.61 4.46 4.45 4.82 4.49 8.26 -
P/RPS 0.60 0.60 0.62 0.59 0.68 0.62 0.49 14.44%
P/EPS 15.73 14.14 11.01 20.87 27.22 18.98 9.81 36.95%
EY 6.36 7.07 9.09 4.79 3.67 5.27 10.19 -26.94%
DY 4.61 3.47 3.59 3.60 2.72 3.04 3.63 17.25%
P/NAPS 2.36 2.38 2.24 2.37 2.63 2.41 2.00 11.65%
Price Multiplier on Announcement Date
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Date 21/11/14 21/08/14 14/05/14 24/02/14 19/11/13 16/08/13 15/05/13 -
Price 4.45 4.62 4.70 4.29 4.72 4.66 9.26 -
P/RPS 0.58 0.60 0.65 0.57 0.66 0.64 0.54 4.87%
P/EPS 15.12 14.17 11.60 20.12 26.66 19.70 11.00 23.60%
EY 6.61 7.06 8.62 4.97 3.75 5.08 9.09 -19.11%
DY 4.79 3.46 3.40 3.73 2.77 2.93 3.24 29.74%
P/NAPS 2.27 2.38 2.36 2.28 2.58 2.51 2.25 0.59%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment